Identification of the degradation product of ezlopitant, a non-peptidic substance p antagonist receptor, by hydrogen deuterium exchange, electrospray ionization tandem mass spectrometry (ESI/MS/MS) and nuclear magnetic resonance (NMR) spectroscopy

被引:9
作者
Kamel, AM
Zandi, KS
Massefski, WW
机构
[1] Pfizer Global Res & Dev, Dept Pharmacokinet, Dynam & Drug Metab, Groton Labs, Groton, CT 06340 USA
[2] Pfizer Global Res & Dev, Radiochem Synthesis, Groton Labs, Groton, CT 06340 USA
[3] Pfizer Global Res & Dev, NMR Spect, Groton Labs, Groton, CT 06340 USA
关键词
ezlopitant; ESI/MS/MS; degradation product identification; NMR; H/D exchange;
D O I
10.1016/S0731-7085(03)00025-6
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The degradation product of ezlopitant was isolated from low specific activity material and identified by solution phase hydrogen/deuterium (H/D) exchange and electrospray ionization tandem mass spectrometry (ESI/MS/MS) to be an isopropyl peroxide analog of ezlopitant. The structure of the degradant was further confirmed by nuclear magnetic resonance (NMR) spectroscopy utilizing complete H-1 and C-13 assignments. Studies were also performed to identify the factors responsible for the oxidative degradation of ezlopitant, which included salt form, storage conditions and salt formation solvent. Of all the variable studies over a 3 weeks period, only a change in the salt form prevented this oxidative degradation. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1211 / 1222
页数:12
相关论文
共 62 条
[61]   Determination of degradation products of sumatriptan succinate using LC-MS and LC-MS-MS [J].
Xu, XH ;
Bartlett, MG ;
Stewart, JT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (03) :367-377
[62]  
ZANDI KS, 1999, 3 INT C IS VANC CAN